442 material Form 8-K filings that 386 companies we cover made with the SEC in March 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Winnebago Industries reported second-quarter fiscal 2025 results for the period ended March 1, 2025, with net revenues down 11.8% year over year to $620.2 million and a net loss of $0.4 million, or $0.02 per diluted share. Adjusted earnings per diluted share fell 79.6% to $0.19, and the company updated its fiscal 2025 outlook to sales of $2.8 billion to $3.0 billion and adjusted earnings per share of $2.75 to $3.75. Shareholders face lower revenue and profit in the quarter, and the updated range is the company's current view of the full year.
Net revenues were $620.2 million, down from $703.6 million a year earlier, with Motorhome RV revenue down 30.4%.
Adjusted EBITDA was $22.8 million, down 54.2% from $49.8 million; gross margin fell to 13.4% from 15.0%.
Fiscal 2025 outlook: sales of $2.8 billion to $3.0 billion, reported EPS of $2.10 to $3.10, adjusted EPS of $2.75 to $3.75.
The company completed a $100 million tender for its 6.25% Senior Secured Notes due 2028 and repurchased $20 million of its stock during the quarter.
H.B. Fuller reported first quarter 2025 results for the period ended March 1, 2025. Net revenue fell 2.7% to $789 million, although organic revenue rose 1.9%, and net income declined to $13 million from $31 million a year earlier. Adjusted EBITDA fell 7% to $114 million, which the company said was as expected, and the full-year 2025 outlook was left unchanged.
Net revenue was $789 million, down 2.7% year-on-year; organic revenue rose 1.9%, driven by volume and pricing
Net income was $13 million versus $31 million a year earlier; reported diluted EPS was $0.24 versus $0.55
Adjusted EBITDA was $114 million, down 7%; adjusted diluted EPS was $0.54 versus $0.67
Full-year 2025 outlook is unchanged, including adjusted EBITDA of $600 million to $625 million; second-quarter adjusted EBITDA is expected at $150 million to $160 million
REX American Resources reported lower fourth-quarter and full fiscal 2024 sales and profit than a year earlier, as lower ethanol and co-product prices reduced revenue. Diluted EPS was $0.63 in the quarter versus $1.16, and $3.30 for the full year versus $3.47. The company also said its One Earth ethanol expansion will finish later than the mid-2025 target and now has a budget of $220-$230 million.
Q4 net sales and revenue were $158.2 million versus $187.6 million; Q4 gross profit was $17.6 million versus $30.4 million.
Full fiscal 2024 net sales and revenue were $642.5 million versus $833.4 million; diluted EPS was $3.30 versus $3.47.
One Earth ethanol expansion is budgeted at $220-$230 million, with completion now expected after the middle of 2025.
On March 25, 2025, the board authorized up to 1.5 million additional shares for repurchase; the company reported $359.1 million in cash and short-term investments and no bank debt as of January 31, 2025.
Worthington Steel reported fiscal 2025 third-quarter net sales of $687.4 million, down 15% from $805.8 million a year earlier, as lower volume and lower selling prices reduced gross margin. Net earnings attributable to controlling interest fell to $13.8 million, or $0.27 per diluted share, from $49.0 million, or $0.98, and the company also declared a $0.16 quarterly dividend.
Net sales of $687.4 million vs $805.8 million in the prior-year quarter, down 15%
Operating income of $18.3 million vs $66.3 million; $7.4 million of asset impairments were recognized
Net earnings per diluted share of $0.27 vs $0.98; adjusted per diluted share of $0.35 vs $0.99
Quarterly dividend of $0.16 per share, payable June 27, 2025, to holders of record on June 13, 2025
Academy Sports and Outdoors reported fourth-quarter fiscal 2024 net sales of $1.68 billion, down 6.6%, and diluted GAAP EPS of $1.89, down 14.5% from $2.21 a year earlier. For the full year, net sales fell 3.7% to $5.93 billion and diluted EPS fell 14.5% to $5.73, and the company gave initial fiscal 2025 guidance for GAAP diluted EPS of $5.40 to $5.85, with the midpoint below the 2024 result.
Q4 comparable sales declined 3.0%, a 190 basis point improvement from the third quarter
Fiscal 2025 guidance: net sales of $6.09 billion to $6.265 billion and GAAP diluted EPS of $5.40 to $5.85
Quarterly dividend raised 18% to $0.13 per share, payable April 17, 2025 to holders of record on March 25, 2025
Company expects the first quarter of 2025 to be the most challenging period for sales and EPS
General Mills reported fiscal 2025 third-quarter results for the quarter ended February 23, 2025, with net sales down 5% to $4.8 billion and diluted EPS down 4% to $1.12. It also lowered its full-year fiscal 2025 outlook, now expecting organic net sales down 2% to down 1.5% and adjusted operating profit and adjusted diluted EPS down 8% to down 7% in constant currency. For shareholders, this points to weaker sales and profit than the company previously expected, which it attributed to retailer inventory reductions and a slowdown in snacking categories.
Third-quarter net sales were $4.8 billion, down 5%; organic net sales were also down 5%, including about 4 points of retailer inventory reductions and the expected reversal of certain second-quarter timing items.
Diluted EPS was $1.12, down 4%; adjusted diluted EPS was $1.00, down 15% in constant currency.
Full-year fiscal 2025 adjusted operating profit and adjusted diluted EPS are now expected to be down 8% to down 7% in constant currency, compared with the previous down 4% to down 2%.
Holistic Margin Management is expected to deliver at least 5% cost of goods sold savings in fiscal 2026, about $600 million, and new cost-savings initiatives target at least $100 million.
Liquidia reported full-year 2024 revenue of $14.0 million, down from $17.5 million, and a net loss of $130.4 million, or $1.66 per share, versus a net loss of $78.5 million, or $1.21 per share, in 2023. Cash and cash equivalents rose to $176.5 million at year-end, and the company amended its HCRx financing agreement to provide up to an additional $100 million, with $25.0 million received at closing. Shareholders face wider losses and lower revenue, while the company awaits possible final FDA approval of YUTREPIA after regulatory exclusivity expires on May 23, 2025.
Revenue fell to $14.0 million from $17.5 million, mainly due to lower sales quantities tied to limited availability of pumps for Treprostinil Injection.
General and administrative expenses rose to $81.6 million from $44.7 million; research and development expenses rose to $47.8 million from $43.2 million.
Net loss was $130.4 million, or $1.66 per share, compared with $78.5 million, or $1.21 per share, in 2023.
The HCRx amendment provides up to $100 million in three tranches; Liquidia received $25.0 million at closing.
Assured Guaranty Ltd. made available the audited 2024 combined financial statements of its subsidiary Assured Guaranty Inc., along with a financial supplement and a fixed income investor presentation. For 2024, the subsidiary reported total revenues of $668 million, down from $799 million in 2023, and net income attributable to Assured Guaranty Inc. of $402 million, down from $424 million.
Total revenues were $668 million in 2024, compared with $799 million in 2023.
Net income attributable to Assured Guaranty Inc. was $402 million in 2024, compared with $424 million in 2023.
Total shareholder's equity was $5,376 million at December 31, 2024, down from $5,795 million a year earlier.
The subsidiary paid $400 million in dividends and redeemed $400 million of common stock in 2024.
Buckle reported fourth-quarter fiscal 2024 net income of $77.2 million, or $1.53 per diluted share, down from $79.6 million, or $1.59 per diluted share, a year earlier. For the full fiscal year ended February 1, 2025, net sales fell 3.4% to $1.218 billion and net income fell to $195.5 million, or $3.89 per diluted share, from $219.9 million, or $4.40 per diluted share. Lower sales and profit are the key takeaways for shareholders, though comparable store sales rose 3.9% in the fourth quarter.
Q4 net sales decreased 0.8% to $379.2 million; comparable store net sales rose 3.9%
Q4 online sales rose 6.4% to $69.7 million
Full-year net sales decreased 3.4% to $1.218 billion; comparable store net sales fell 2.7%
Full-year diluted EPS was $3.89, versus $4.40 in fiscal 2023
Brown-Forman reported third-quarter fiscal 2025 net sales down 3% to $1.0 billion, operating income down 25% to $280 million, and diluted earnings per share down 5% to $0.57, all on a reported basis. On an organic basis, which excludes divestitures, currency and other items, sales rose 6% and operating income rose 23%. The company reaffirmed its fiscal 2025 organic growth outlook of 2% to 4% for both net sales and operating income.
Nine-month reported net sales fell 4% to $3.1 billion and diluted EPS fell 4% to $1.53; nine-month operating income fell 13% to $902 million.
Nine-month results include a $78 million gain on the sale of the Duckhorn investment, worth $0.14 per diluted share, and $33 million of restructuring and other charges.
Fiscal 2025 outlook reaffirmed: organic net sales growth and organic operating income growth each of 2% to 4%, with capital expenditures of $180 million to $190 million.
The forecast effective tax rate was updated to approximately 20% to 22% from 21% to 23%.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.